Telotristat etiprate
LX1606.1-302-CS
Phase 3 small_molecule completed
Quick answer
Telotristat etiprate for Carcinoid Syndrome is a Phase 3 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 5 ClinicalTrials.gov record(s).
Program details
- Company
- LEXICON PHARMACEUTICALS, INC.
- Indication
- Carcinoid Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed